We know that obesity is a complex disease that affects people in different ways. By listening to the experiences of people who are overweight or living with obesity as well as healthcare professionals around the world, we continue to deepen our understanding of the disease, its related conditions, and its impact on daily life.
Through research efforts, our scientists developed an investigational medicine called maridebart cafraglutide, also known as MariTide. The MARITIME clinical studies will investigate MariTide’s safety and effectiveness in lowering body weight and improving health outcomes.
Your participation could play an important role in helping to understand obesity and its related conditions, and help develop a potential treatment option.
Additional studies may be announced in the future.
Connect with us
